0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Hospital Acquired Infection Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-17N10719
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hospital Acquired Infection Testing Market Research Report 2022
BUY CHAPTERS

Hospital Acquired Infection Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-17N10719
Report
November 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hospital Acquired Infection Testing - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Hospital Acquired Infection Testing - Market

Hospital Acquired Infection Testing - Market

The global market for Hospital Acquired Infection Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hospital Acquired Infection Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hospital Acquired Infection Testing by region & country, by Type, and by Application.
The Hospital Acquired Infection Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Acquired Infection Testing.
Market Segmentation

Scope of Hospital Acquired Infection Testing - Market Report

Report Metric Details
Report Name Hospital Acquired Infection Testing - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
  • Molecular Diagnostics
  • Blood Tests
  • Urinalysis
Segment by Application
  • Urinary Tract Infections
  • Pneumonia
  • Surgical Site Infections
  • Bloodstream Infections
  • Other Hospital Infections
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioMerieux, Abbott Laboratories, Alere, Roche, Siemens Healthcare, Becton Dickenson, Cepheid, Roche Holding AG, Thermo Fisher Scientific, Seegene, Qiagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Hospital Acquired Infection Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Hospital Acquired Infection Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Hospital Acquired Infection Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Hospital Acquired Infection Testing - Market report?

Ans: The main players in the Hospital Acquired Infection Testing - Market are BioMerieux, Abbott Laboratories, Alere, Roche, Siemens Healthcare, Becton Dickenson, Cepheid, Roche Holding AG, Thermo Fisher Scientific, Seegene, Qiagen

What are the Application segmentation covered in the Hospital Acquired Infection Testing - Market report?

Ans: The Applications covered in the Hospital Acquired Infection Testing - Market report are Urinary Tract Infections, Pneumonia, Surgical Site Infections, Bloodstream Infections, Other Hospital Infections

What are the Type segmentation covered in the Hospital Acquired Infection Testing - Market report?

Ans: The Types covered in the Hospital Acquired Infection Testing - Market report are Molecular Diagnostics, Blood Tests, Urinalysis

1 Market Overview
1.1 Hospital Acquired Infection Testing Product Introduction
1.2 Global Hospital Acquired Infection Testing Market Size Forecast
1.3 Hospital Acquired Infection Testing Market Trends & Drivers
1.3.1 Hospital Acquired Infection Testing Industry Trends
1.3.2 Hospital Acquired Infection Testing Market Drivers & Opportunity
1.3.3 Hospital Acquired Infection Testing Market Challenges
1.3.4 Hospital Acquired Infection Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hospital Acquired Infection Testing Players Revenue Ranking (2023)
2.2 Global Hospital Acquired Infection Testing Revenue by Company (2019-2024)
2.3 Key Companies Hospital Acquired Infection Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Hospital Acquired Infection Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Hospital Acquired Infection Testing
2.6 Hospital Acquired Infection Testing Market Competitive Analysis
2.6.1 Hospital Acquired Infection Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Hospital Acquired Infection Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infection Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Molecular Diagnostics
3.1.2 Blood Tests
3.1.3 Urinalysis
3.2 Global Hospital Acquired Infection Testing Sales Value by Type
3.2.1 Global Hospital Acquired Infection Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hospital Acquired Infection Testing Sales Value, by Type (2019-2030)
3.2.3 Global Hospital Acquired Infection Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Urinary Tract Infections
4.1.2 Pneumonia
4.1.3 Surgical Site Infections
4.1.4 Bloodstream Infections
4.1.5 Other Hospital Infections
4.2 Global Hospital Acquired Infection Testing Sales Value by Application
4.2.1 Global Hospital Acquired Infection Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hospital Acquired Infection Testing Sales Value, by Application (2019-2030)
4.2.3 Global Hospital Acquired Infection Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Hospital Acquired Infection Testing Sales Value by Region
5.1.1 Global Hospital Acquired Infection Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hospital Acquired Infection Testing Sales Value by Region (2019-2024)
5.1.3 Global Hospital Acquired Infection Testing Sales Value by Region (2025-2030)
5.1.4 Global Hospital Acquired Infection Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Hospital Acquired Infection Testing Sales Value, 2019-2030
5.2.2 North America Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Hospital Acquired Infection Testing Sales Value, 2019-2030
5.3.2 Europe Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Hospital Acquired Infection Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Hospital Acquired Infection Testing Sales Value, 2019-2030
5.5.2 South America Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Hospital Acquired Infection Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hospital Acquired Infection Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hospital Acquired Infection Testing Sales Value
6.3 United States
6.3.1 United States Hospital Acquired Infection Testing Sales Value, 2019-2030
6.3.2 United States Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hospital Acquired Infection Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hospital Acquired Infection Testing Sales Value, 2019-2030
6.4.2 Europe Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hospital Acquired Infection Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hospital Acquired Infection Testing Sales Value, 2019-2030
6.5.2 China Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hospital Acquired Infection Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hospital Acquired Infection Testing Sales Value, 2019-2030
6.6.2 Japan Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hospital Acquired Infection Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hospital Acquired Infection Testing Sales Value, 2019-2030
6.7.2 South Korea Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hospital Acquired Infection Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hospital Acquired Infection Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hospital Acquired Infection Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hospital Acquired Infection Testing Sales Value, 2019-2030
6.9.2 India Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hospital Acquired Infection Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BioMerieux
7.1.1 BioMerieux Profile
7.1.2 BioMerieux Main Business
7.1.3 BioMerieux Hospital Acquired Infection Testing Products, Services and Solutions
7.1.4 BioMerieux Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.1.5 BioMerieux Recent Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Profile
7.2.2 Abbott Laboratories Main Business
7.2.3 Abbott Laboratories Hospital Acquired Infection Testing Products, Services and Solutions
7.2.4 Abbott Laboratories Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Laboratories Recent Developments
7.3 Alere
7.3.1 Alere Profile
7.3.2 Alere Main Business
7.3.3 Alere Hospital Acquired Infection Testing Products, Services and Solutions
7.3.4 Alere Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Roche Recent Developments
7.4 Roche
7.4.1 Roche Profile
7.4.2 Roche Main Business
7.4.3 Roche Hospital Acquired Infection Testing Products, Services and Solutions
7.4.4 Roche Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Roche Recent Developments
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Profile
7.5.2 Siemens Healthcare Main Business
7.5.3 Siemens Healthcare Hospital Acquired Infection Testing Products, Services and Solutions
7.5.4 Siemens Healthcare Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Siemens Healthcare Recent Developments
7.6 Becton Dickenson
7.6.1 Becton Dickenson Profile
7.6.2 Becton Dickenson Main Business
7.6.3 Becton Dickenson Hospital Acquired Infection Testing Products, Services and Solutions
7.6.4 Becton Dickenson Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Becton Dickenson Recent Developments
7.7 Cepheid
7.7.1 Cepheid Profile
7.7.2 Cepheid Main Business
7.7.3 Cepheid Hospital Acquired Infection Testing Products, Services and Solutions
7.7.4 Cepheid Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Cepheid Recent Developments
7.8 Roche Holding AG
7.8.1 Roche Holding AG Profile
7.8.2 Roche Holding AG Main Business
7.8.3 Roche Holding AG Hospital Acquired Infection Testing Products, Services and Solutions
7.8.4 Roche Holding AG Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Roche Holding AG Recent Developments
7.9 Thermo Fisher Scientific
7.9.1 Thermo Fisher Scientific Profile
7.9.2 Thermo Fisher Scientific Main Business
7.9.3 Thermo Fisher Scientific Hospital Acquired Infection Testing Products, Services and Solutions
7.9.4 Thermo Fisher Scientific Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Thermo Fisher Scientific Recent Developments
7.10 Seegene
7.10.1 Seegene Profile
7.10.2 Seegene Main Business
7.10.3 Seegene Hospital Acquired Infection Testing Products, Services and Solutions
7.10.4 Seegene Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Seegene Recent Developments
7.11 Qiagen
7.11.1 Qiagen Profile
7.11.2 Qiagen Main Business
7.11.3 Qiagen Hospital Acquired Infection Testing Products, Services and Solutions
7.11.4 Qiagen Hospital Acquired Infection Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Qiagen Recent Developments
8 Industry Chain Analysis
8.1 Hospital Acquired Infection Testing Industrial Chain
8.2 Hospital Acquired Infection Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hospital Acquired Infection Testing Sales Model
8.5.2 Sales Channel
8.5.3 Hospital Acquired Infection Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Hospital Acquired Infection Testing Market Trends
    Table 2. Hospital Acquired Infection Testing Market Drivers & Opportunity
    Table 3. Hospital Acquired Infection Testing Market Challenges
    Table 4. Hospital Acquired Infection Testing Market Restraints
    Table 5. Global Hospital Acquired Infection Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Hospital Acquired Infection Testing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Hospital Acquired Infection Testing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Hospital Acquired Infection Testing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Hospital Acquired Infection Testing
    Table 10. Global Hospital Acquired Infection Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infection Testing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Hospital Acquired Infection Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Hospital Acquired Infection Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Hospital Acquired Infection Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Hospital Acquired Infection Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Hospital Acquired Infection Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Hospital Acquired Infection Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Hospital Acquired Infection Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Hospital Acquired Infection Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Hospital Acquired Infection Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Hospital Acquired Infection Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Hospital Acquired Infection Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Hospital Acquired Infection Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Hospital Acquired Infection Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Hospital Acquired Infection Testing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Hospital Acquired Infection Testing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Hospital Acquired Infection Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Hospital Acquired Infection Testing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Hospital Acquired Infection Testing Sales Value, (2025-2030) & (US$ Million)
    Table 31. BioMerieux Basic Information List
    Table 32. BioMerieux Description and Business Overview
    Table 33. BioMerieux Hospital Acquired Infection Testing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of BioMerieux (2019-2024)
    Table 35. BioMerieux Recent Developments
    Table 36. Abbott Laboratories Basic Information List
    Table 37. Abbott Laboratories Description and Business Overview
    Table 38. Abbott Laboratories Hospital Acquired Infection Testing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Abbott Laboratories (2019-2024)
    Table 40. Abbott Laboratories Recent Developments
    Table 41. Alere Basic Information List
    Table 42. Alere Description and Business Overview
    Table 43. Alere Hospital Acquired Infection Testing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Alere (2019-2024)
    Table 45. Alere Recent Developments
    Table 46. Roche Basic Information List
    Table 47. Roche Description and Business Overview
    Table 48. Roche Hospital Acquired Infection Testing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Roche (2019-2024)
    Table 50. Roche Recent Developments
    Table 51. Siemens Healthcare Basic Information List
    Table 52. Siemens Healthcare Description and Business Overview
    Table 53. Siemens Healthcare Hospital Acquired Infection Testing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Siemens Healthcare (2019-2024)
    Table 55. Siemens Healthcare Recent Developments
    Table 56. Becton Dickenson Basic Information List
    Table 57. Becton Dickenson Description and Business Overview
    Table 58. Becton Dickenson Hospital Acquired Infection Testing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Becton Dickenson (2019-2024)
    Table 60. Becton Dickenson Recent Developments
    Table 61. Cepheid Basic Information List
    Table 62. Cepheid Description and Business Overview
    Table 63. Cepheid Hospital Acquired Infection Testing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Cepheid (2019-2024)
    Table 65. Cepheid Recent Developments
    Table 66. Roche Holding AG Basic Information List
    Table 67. Roche Holding AG Description and Business Overview
    Table 68. Roche Holding AG Hospital Acquired Infection Testing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Roche Holding AG (2019-2024)
    Table 70. Roche Holding AG Recent Developments
    Table 71. Thermo Fisher Scientific Basic Information List
    Table 72. Thermo Fisher Scientific Description and Business Overview
    Table 73. Thermo Fisher Scientific Hospital Acquired Infection Testing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Thermo Fisher Scientific (2019-2024)
    Table 75. Thermo Fisher Scientific Recent Developments
    Table 76. Seegene Basic Information List
    Table 77. Seegene Description and Business Overview
    Table 78. Seegene Hospital Acquired Infection Testing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Seegene (2019-2024)
    Table 80. Seegene Recent Developments
    Table 81. Qiagen Basic Information List
    Table 82. Qiagen Description and Business Overview
    Table 83. Qiagen Hospital Acquired Infection Testing Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Hospital Acquired Infection Testing Business of Qiagen (2019-2024)
    Table 85. Qiagen Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Hospital Acquired Infection Testing Downstream Customers
    Table 89. Hospital Acquired Infection Testing Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Hospital Acquired Infection Testing Product Picture
    Figure 2. Global Hospital Acquired Infection Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Hospital Acquired Infection Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Hospital Acquired Infection Testing Report Years Considered
    Figure 5. Global Hospital Acquired Infection Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hospital Acquired Infection Testing Revenue in 2023
    Figure 7. Hospital Acquired Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Molecular Diagnostics Picture
    Figure 9. Blood Tests Picture
    Figure 10. Urinalysis Picture
    Figure 11. Global Hospital Acquired Infection Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Hospital Acquired Infection Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Urinary Tract Infections
    Figure 14. Product Picture of Pneumonia
    Figure 15. Product Picture of Surgical Site Infections
    Figure 16. Product Picture of Bloodstream Infections
    Figure 17. Product Picture of Other Hospital Infections
    Figure 18. Global Hospital Acquired Infection Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Hospital Acquired Infection Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Hospital Acquired Infection Testing Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Hospital Acquired Infection Testing Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Hospital Acquired Infection Testing Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Hospital Acquired Infection Testing Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Hospital Acquired Infection Testing Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Hospital Acquired Infection Testing Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Hospital Acquired Infection Testing Sales Value (%), (2019-2030)
    Figure 31. United States Hospital Acquired Infection Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Hospital Acquired Infection Testing Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Hospital Acquired Infection Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Hospital Acquired Infection Testing Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Hospital Acquired Infection Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Hospital Acquired Infection Testing Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Hospital Acquired Infection Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Hospital Acquired Infection Testing Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Hospital Acquired Infection Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Hospital Acquired Infection Testing Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Hospital Acquired Infection Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Hospital Acquired Infection Testing Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Hospital Acquired Infection Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Hospital Acquired Infection Testing Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Hospital Acquired Infection Testing Sales Value by Application (%), 2023 VS 2030
    Figure 52. Hospital Acquired Infection Testing Industrial Chain
    Figure 53. Hospital Acquired Infection Testing Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS